@UCSDCancer

NCI-designated & Comprehensive. Research, clinical trials, transformative care, survivorship, public-policy changing discoveries. #DeliveringDiscoveries

 San Diego, California
moorescancercenter.ucsd.edu/
Joined December 2021
  • Tweets1.7K
  • Following235
  • Followers1.4K
1KMedia
Shuvro Prokash Nandi, PhD, is an Assistant Project Scientist in the Alexandrov Lab at UC San Diego. His work focuses on cancer genomics, mutational signatures and the biological processes that shape somatic mutations. He develops advanced sequencing technologies, including duplex sequencing for ultra-sensitive detection of rare mutations. His newer polymerase-based extensions are designed to read unrepaired DNA damage directly, rather than only the mutations it leaves behind. These methods are applied to cancer risk assessment, environmental mutagenesis and precision oncology. Watch now: bit.ly/4hXVsat #ResearcherSpotlight #CancerGenomics #Genomics #PrecisionOncology
Inside the Lab Researcher Spotlight, featuring Shuvro Prokash Nandi, PhD. The background is a blue abstract design with circular patterns and a play button overlay. Shuvro Prokash Nandi is at the bottom right.

ALT Inside the Lab Researcher Spotlight, featuring Shuvro Prokash Nandi, PhD. The background is a blue abstract design with circular patterns and a play button overlay. Shuvro Prokash Nandi is at the bottom right.

1
55
Introducing the PREDICT Initiative at UC San Diego Moores Cancer Center. Prevention, Risk Assessment, Early Detection and Interception of Cancer through Technology (PREDICT) unites clinical care, molecular science, data science and artificial intelligence with one goal: to prevent more cancers, detect them earlier and intercept them at their earliest stages. Learn more: bit.ly/4yhtm05 #CancerPrevention #EarlyDetection #AI #CancerResearch #PREDICT
Three images depict a presentation event. The first shows a speaker on stage with a large PREDICT Initiative slide. The second image features a panel of three individuals seated, engaged in discussion. The third image shows another speaker at a podium in front of a presentation slide.

ALT Three images depict a presentation event. The first shows a speaker on stage with a large PREDICT Initiative slide. The second image features a panel of three individuals seated, engaged in discussion. The third image shows another speaker at a podium in front of a presentation slide.

1
2
84
Breast cancer can affect young women, too. Watch Moores Cancer Center member Anne Wallace, MD, UC San Diego Health breast surgical oncologist and plastic surgeon, discuss the signs young women should know in her FOX 5 San Diego interview: bit.ly/47oE2yV
48
For the second time, UC San Diego has been named the No. 1 public university for research in Washington Monthly’s 2026 College Guide and Rankings. The university also retained its No. 6 ranking among all U.S. research universities. We’re proud to be part of a research community advancing discovery, from the lab to the clinic. Learn more: bit.ly/3TNKpIH #UCSanDiego #Research #CancerResearch #Discovery
A scientist in a laboratory is working with a pipette, surrounded by lab equipment and shelves filled with boxes. A notebook with handwritten notes is open in the foreground.

ALT A scientist in a laboratory is working with a pipette, surrounded by lab equipment and shelves filled with boxes. A notebook with handwritten notes is open in the foreground.

65
Colorectal cancer is increasingly being diagnosed in younger adults, and awareness can save lives. Moores Cancer Center Member Rohit Loomba, MD, recently spoke with FOX 5 San Diego about this concerning trend and stressed the urgent need for greater awareness, prevention and early detection. Watch the interview: bit.ly/4yj3Hny #ColorectalCancer #EarlyDetection #CancerPrevention #CancerAwareness
Rohit Loomba, MD, speaking with FOX 5 San Diego

ALT Rohit Loomba, MD, speaking with FOX 5 San Diego

1
33
On this episode of the Science Of podcast, Alexander Wallace, PhD, discusses how substance use affects neurodevelopment and aerobic fitness in young adults. Listen now: bit.ly/4jDq2IG #ScienceOf #Podcast #SubstanceUse
2
62
What if we could change a patient’s treatment before their cancer visibly progresses? Moores Cancer Center Member Rebecca Shatsky, MD, breaks down the practice-changing SERENA-6 trial in Cancer Network. The study used ctDNA to detect emerging ESR1 mutations early and switch therapy, nearly doubling median progression-free survival (approximately 17 vs. 9 months). Watch the interview: bit.ly/4im1YJi #BreastCancer #ctDNA #PrecisionOncology #CancerResearch
A person with long hair and glasses is smiling, standing in front of a gradient background. The text reads, "cancernetwork, home of the journal Oncology. Rebecca Shatsky, MD, on precision breast cancer treatment.

ALT A person with long hair and glasses is smiling, standing in front of a gradient background. The text reads, "cancernetwork, home of the journal Oncology. Rebecca Shatsky, MD, on precision breast cancer treatment.

64
Exercise may help breast cancer survivors think more clearly and slow cellular aging. Sheri Hartman, PhD, a member of Moores Cancer Center at UC San Diego Health, joined CBS 8 to discuss two studies published in the *Journal of the National Cancer Institute*. The findings link a 12-month exercise program to improved attention and memory and slower epigenetic aging. Watch the interview: bit.ly/4jn1MdT #BreastCancer #Survivorship #Exercise #CancerResearch
This image shows a person smiling with dark hair, wearing a blue top. The background has a gradient of colors from yellow to blue. On the right side, the CBS8 logo is displayed alongside the text: "Sheri Hartman, PhD, on Exercise and Cancer Survivorship.

ALT This image shows a person smiling with dark hair, wearing a blue top. The background has a gradient of colors from yellow to blue. On the right side, the CBS8 logo is displayed alongside the text: "Sheri Hartman, PhD, on Exercise and Cancer Survivorship.

51
Why is pancreatic cancer so difficult to treat? New research co-led by Moores Cancer Center Director Diane M. Simeone, MD, reveals how cancer cells change and resist treatment, offering new insights into more effective therapies. Read more: go.ucsd.edu/47jbA1i
52
UC San Diego Moores Cancer Center's Lyudmila Bazhenova, MD, is featured in Medscape coverage of two phase 3 trials evaluating first-line combination therapies for advanced NSCLC with EGFR exon 20 insertions. The report examines emerging approaches that may expand treatment options for these patients. Read more: bit.ly/4AJDtxa #LungCancer #NSCLC #MooresCancerCenter #Medscape
74
Moores member Sandip Patel, MD, FASCO, moderated @OncLive's workshop on HER2-mutated NSCLC. Frontline zongertinib showed a 76% ORR and 47% intracranial ORR in active brain metastases. Read more: bit.ly/4rZ4g4v
This image features a professional with a smile, wearing a white coat and tie, alongside the text "OncLive" and "Sandip Patel, MD Featured in OncLive" against a blue and yellow gradient background.

ALT This image features a professional with a smile, wearing a white coat and tie, alongside the text "OncLive" and "Sandip Patel, MD Featured in OncLive" against a blue and yellow gradient background.

71
UC San Diego Moores Cancer Center's Rana R. McKay, MD, discusses NGS versus IHC testing for PTEN deficiency in metastatic hormone-sensitive prostate cancer. In this UroToday interview, she explains how each test informs treatment decisions following the capivasertib-abiraterone approval, and recommends NGS for BRCA alterations alongside IHC for PTEN status. Watch the video: bit.ly/4ddlYen #ProstateCancer #MooresCancerCenter #UroToday
77
Breast Cancer Awareness Month: Cancer care doesn’t end when treatment does. Kimberly Podsada, MSN, NP-C, founded the Breast Cancer Survivorship Program at Moores Cancer Center to help patients navigate life after treatment. With support from leaders including Anne Wallace, MD, the program connects survivors with resources for wellness, recovery and long-term health. Read the story and explore our FY25 Annual Report! Read the story: bit.ly/4rQ5fUq FY25 Annual Report: bit.ly/4rSBCSA #BreastCancerAwarenessMonth #BreastCancer
72
UC San Diego Health is the first hospital to offer a radioactive bandage for treating skin cancer. Parag Sanghvi, MD, MSPH, discusses the approach, which has also drawn coverage in Dermatology Digest and Onco Zine. Read more: bit.ly/3TYNtlt #SkinCancer #RadiationOncology #MooresCancerCenter
2
95
After being diagnosed with multiple myeloma, longtime UC San Diego Health emergency physician Stephen Hayden, MD, received CAR T-cell therapy through the CARTITUDE-6 clinical trial at Moores Cancer Center, led by Caitlin Costello, MD. Now in remission, Dr. Hayden continues teaching future doctors and was recently honored by the San Diego Padres. Read his story: bit.ly/4z95a0M
1
114
Behind every research milestone is a team that makes it possible. Meet Raluca Ciochina, Executive Assistant to J. Silvio Gutkind, PhD, UC San Diego Moores Cancer Associate Director of Basic Science. Her administrative, operational and programmatic support helps advance Moores' fundamental research programs and leadership priorities, including the annual scientific retreat. Learn more: bit.ly/4hFNv9U #PeopleBehindTheMission #MooresCancerCenter
87
For Breast Cancer Awareness Month: New research led by Moores Cancer Center member Sheri Hartman, PhD, suggests exercise may support attention and slow biological aging in breast cancer survivors. Published in @JNCI. go.ucsd.edu/47sddcX
65
Advancing innovative clinical trials is central to our mission at Moores Cancer Center at UC San Diego Health. STRIPe (STudy of Real-world Individualized Precision-oncology) is the first randomized precision oncology trial of its kind, testing personalized, molecularly matched treatment strategies against standard-of-care therapy for patients with advanced cancers. Led by Jason Sicklick, MD, FACS, and Shumei Kato, MD, the Phase II trial builds on more than a decade of precision oncology research. Learn more: bit.ly/4rKmGWG
1
1
3
258
Diagnosed with synovial sarcoma at 16, Danielle McLaughlin knows cancer care from both sides: as a patient and as a leader at UC San Diego Health. Today, she helps expand access to coordinated, compassionate cancer care, informed by her own experience. Read her story: bit.ly/4dvQmRx
1
72
Thyroid cancer is often diagnosed at a younger age than most other adult cancers and is almost three times more common in women than in men. At Moores Cancer Center at UC San Diego Health, our multidisciplinary teams provide specialized care for people with thyroid cancer. Learn more about thyroid cancer care at UC San Diego Health: bit.ly/4z9JxgS
65
Load more